Cytokinetics Inc


Market Cap$7.65B

Compare Cytokinetics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cytokinetics IncCytokinetics Inc-14.50%136%--1.6
marketMarket Avg58.91.26%30%-1
HealthcareHealthcare Avg64.71.29%15%7.30.9

Target Price by Analysts

38.3% upsideCytokinetics Target Price DetailsTarget Price

Current Fair Value

3.6% upside

Undervalued by 3.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$7.65 Billion
Enterprise Value$7.66 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-5.45
Outstanding Shares104,576,087
Avg 30 Day Volume2,649,772


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-14.54
Price to Sales-
Price to Book Ratio-17.89
Enterprise Value to Revenue1016.81
Enterprise Value to EBIT-15.43
Enterprise Value to Net Income-15
Total Debt to Enterprise0.08
Debt to Equity-1.6

Revenue Sources

No data

ESG Score

No data

About Cytokinetics Inc

CEO: Robert Blum